Literature DB >> 14704126

Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells.

Yu-Xiu Li1, Zhi-Bin Lin, Huan-Ran Tan.   

Abstract

AIM: To study the effect of wild type (wt) p53 gene transfection on drug resistant human hepatocellular carcinoma (HCC) cells induced by 5-Fluorouracil (5-FU).
METHODS: The cytotoxicity of anticancer drugs on Bel7402 and Bel7402/5-FU cells was assessed using SRB assay. p53 expression was detected at its mRNA level by RT-PCR assay and at its protein level Western blot or immunocytochemistry assay in Bel7402/5-FU cells transfected with either control vector or wt p53. AnnexinV-FITC/PI double labeled assay was performed to detect apoptosis. The chemosensitivity of Bel7402/5-FU cells transfected with wt p53 was assessed using SRB assay.
RESULTS: Bel7402/5-FU cells exhibited cross-resistance to vincristine, doxorubicin, paclitaxel, and so on. wt p53 gene transfection upregulated the expression of p53 in Bel7402/5-FU cells. wt p53 was able to greatly inhibit cell proliferation and significantly induce apoptosis in Bel7402/5-FU cells. Moreover, wt p53 gene transfection increased the chemosensitivity of Bel7402/5-FU cells to some anticancer drugs.
CONCLUSION: These results indicated that the wt p53 gene transfection not only induced suppression of cell growth, but also increased the sensitivity of Bel7402/5-FU cells to 5-FU, vincristine, and doxorubicin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14704126

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  7 in total

Review 1.  p53 gene in treatment of hepatic carcinoma: status quo.

Authors:  Yong-Song Guan; Zi La; Lin Yang; Qing He; Ping Li
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

2.  The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia.

Authors:  Philip Saunders; Adam Cisterne; Jocelyn Weiss; Kenneth F Bradstock; Linda J Bendall
Journal:  Haematologica       Date:  2010-10-15       Impact factor: 9.941

3.  Modulation of the pentose phosphate pathway alters phase I metabolism of testosterone and dextromethorphan in HepG2 cells.

Authors:  Wen-jing Xiao; Ting Ma; Chun Ge; Wen-juan Xia; Yong Mao; Run-bin Sun; Xiao-yi Yu; Ji-ye Aa; Guang-ji Wang
Journal:  Acta Pharmacol Sin       Date:  2015-01-26       Impact factor: 6.150

4.  Ethylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells.

Authors:  Alokita Karmakar; Stacie M Bratton; Enkeleda Dervishi; Anindya Ghosh; Meena Mahmood; Yang Xu; Lamya Mohammed Saeed; Thikra Mustafa; Dan Casciano; Anna Radominska-Pandya; Alexandru S Biris
Journal:  Int J Nanomedicine       Date:  2011-05-18

5.  {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3.

Authors:  Ye Li; Wenjing Wang; Xiaoxue Xu; Shiyue Sun; Xiaoyu Xu; Xian-jun Qu
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

6.  Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.

Authors:  Chengyong Dong; Baofeng Zhao; Fei Long; Ying Liu; Zhenzhen Liu; Song Li; Xuejun Yang; Deguang Sun; Haibo Wang; Qinlong Liu; Rui Liang; Yan Li; Zhenming Gao; Shujuan Shao; Qing Robert Miao; Liming Wang
Journal:  Oncotarget       Date:  2016-02-23

Review 7.  Models for Understanding Resistance to Chemotherapy in Liver Cancer.

Authors:  Jose J G Marin; Elisa Herraez; Elisa Lozano; Rocio I R Macias; Oscar Briz
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.